These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Antibacterial combination therapy].
    Author: Tauchnitz C.
    Journal: Z Gesamte Inn Med; 1977 Jul 15; 32(14):Suppl 219-22. PubMed ID: 919646.
    Abstract:
    Reasons for the use of antibacterial combinations are synergistic effects and delayed development of bacterial resistance. On the basis of numerous experiments in vitro the opinion is supported that a clinically useful synergism depends on the addition of an aminoglycoside, the second compound being either one of the penicillins or cephalosporins, or a polymyxin, or a bacteriostatic agent like tetracycline, macrolide, and lincomycine. The decrease of MBC and MIC values varies according to the species and strains of bacteria and in dependence on the components of antibiotic combinations. Combination therapy with antibacterial synergism is indicated in life-threatening infections and in order to suppress bacterial persistences. Combinations with antagonistic effects should be avoided. The use of multiple antibiotics for broader spectrum only is not supported.
    [Abstract] [Full Text] [Related] [New Search]